about
Prophylactic aspirin therapy does not increase faecal calprotectin concentrationsWorsening of gastroesophageal reflux symptoms in professional singers during performances.Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative?Can chronic gastritis cause an increase in fecal calprotectin concentrations?Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.Adverse reactions to food: allergies and intolerances.Autoimmune enteropathy in children and adults.Classification of malabsorption syndromes.Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.Looking for celiac disease in Italian women with endometriosis: a case control studyEndometriosis, need for a multidisciplinary clinical setting: the internist's point of view.Systematic review: Sprue-like enteropathy associated with olmesartan.Sufficient evidence that 12 g of lactose is tolerated by most adults with lactose malabsorption and intolerance but insufficient evidence on the effectiveness of therapeutical strategies tested so far.Lactose in drugs: avoided or allowed to lactose maldigesters?Fecal calprotectin in first-degree relatives of patients with ulcerative colitis.Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation.Folic acid supplementation during methotrexate treatment: nonsense?Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth.Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms.Non-life-threatening sepsis: report of two cases.ECG signs of biatrial enlargement in a young adult.Anisakis infestation: a case of acute abdomen mimicking Crohn's disease and eosinophilic gastroenteritisDirect visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation studyReliability of the “immersion technique” during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsiaLink Between Helicobacter pylori Infection and Iron-Deficiency Anaemia in Patients with Coeliac DiseaseFecal calprotectin concentrations in alcoholic patientsProbiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study.Role of dental plaque in the transmission of Helicobacter pylori infectionHelicobacter pylori eradication helps resolve pyloric and duodenal stenosisHelicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphomaGlobus pharyngis: was it a stroke of lightning?Immunohistochemical analysis of ZO-1 in the duodenal mucosa of patients with untreated and treated celiac diseaseA highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center studyFaecal calprotectin concentrations in untreated coeliac patientsIntestine: organ or apparatus?Gastrointestinal involvement in a case of hereditary angioedema: could the early weaning have had a role?Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of cautionClinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study
P50
Q28200066-C613722D-FED9-40F7-B3D7-42BF762707B6Q30540329-87798057-AA42-4092-A290-3552F4C387EEQ33396814-0C019003-0A53-4B6A-AC98-4F303809CB52Q33998635-BD27335D-5C97-42B0-91ED-231CD16C0B6EQ34395824-6CE7A523-559F-452D-8417-9EBEB20DA3A2Q34773134-59CBBDA9-058F-4BA2-AB34-7A2058B02E6EQ34955595-4A95684D-EBD1-441A-BB6F-5490714865D6Q37145669-12F15D0C-ABDC-4F62-89CD-94FEBA95B097Q37432284-BCF6360A-0D8B-4FA7-B043-C273443BE547Q37706290-2F677D81-DC35-41E0-A26A-00D0F5F0BFE1Q37744758-EC48F690-447A-420A-9EBC-6AF37D655506Q38209994-A0A2E477-CB03-4585-9513-77908B4CB844Q42879258-371CAAF1-E98F-4A5A-A712-FFA6F1D1D705Q43087429-55FAFF5F-6011-4F6E-982F-102544A3D710Q44103686-66009696-E58A-40FD-8B89-3E5A0AB8019BQ44753605-6D4EB1DA-1BA6-4BC0-920A-2848C33AABA6Q45229001-150F79B6-7031-4A6F-8863-D0E2CA928099Q45278815-DE4FF9B6-EA6D-452D-AA9B-43963CB28BACQ46085888-42140BF6-68E8-4CAF-AFF5-B96CBA3F6337Q46216926-367F6BB9-0D10-4F79-9EE2-7CD53403E5C4Q46461219-3266D98D-FF6D-4291-AC2C-3088651EAA39Q49181430-7F94591D-1374-4454-8B17-8702B02BE1CFQ54661007-00DF30C4-3573-4CC2-9F7D-CD35FBCD547AQ56853367-B8D5ADB4-ED03-4BC1-AA9A-C7ACEE75EA52Q61196160-82986AAF-330C-44C4-8833-568D6F235306Q61196163-586BD9BE-4D6A-44D2-A7E5-C4087F72405AQ61196172-5800ABD0-F206-43E3-9E73-C04F03EDC0A4Q63464421-432294E0-4EA8-4A14-AFFE-607C0290AF85Q64882272-0E495D46-05A7-47BA-A762-12029721A351Q71304047-B053B19E-9447-409A-9DAB-4263E953555CQ71698922-D0CFA390-548A-49CB-A137-CB2A5E177C4DQ72414779-FFCA36FD-9FE7-4D6C-B479-5D0DCDE0D140Q73372013-BC1BB168-6A3D-4235-B2D6-CC52887E2215Q74806376-9709B3E3-DB53-4F06-9B64-27F373CEF150Q79658674-2AD17A5E-AAEC-44E3-8977-FE211DECFB8FQ80573884-4DDD4574-4E66-41C4-A63E-789FC094985DQ81137414-311B0FEA-7416-44BB-A1AF-7FBED1AD5612Q81304219-5618CD1A-4F02-4D65-9342-3C8CD08DB6FEQ81493361-CDF730AF-B9E6-43A3-8B9C-C92A0EA9A6EBQ84043115-83EC9C65-95F9-4E9F-9DD3-145888B08D26
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Massimo Montalto
@ast
Massimo Montalto
@en
Massimo Montalto
@es
Massimo Montalto
@nl
Massimo Montalto
@sl
type
label
Massimo Montalto
@ast
Massimo Montalto
@en
Massimo Montalto
@es
Massimo Montalto
@nl
Massimo Montalto
@sl
prefLabel
Massimo Montalto
@ast
Massimo Montalto
@en
Massimo Montalto
@es
Massimo Montalto
@nl
Massimo Montalto
@sl
P106
P1153
7006247089
P21
P31
P496
0000-0001-8819-3684